Cognition Therapeutics is a biotechnology and pharmaceutical company that was founded by Gilbert Rishton and Susan Catalano in 2007, and is headquartered in Pittsburgh, Pennsylvania. Cognition Therapeutics engages in drug development and discovery to develop novel approaches to the treatment of central nervous system disorders. The companies treatment approach to central nervous system disorders, such as Alzheimers disease and other neurodegenerative disorders, is to prevent the accumulation of toxic proteins associated with central nervous system disorders through the discovery and application of small molecule drug therapies.
Chief Medicinal Chemistry Advisor
Senior Vice President
President & CEO
Chief Medical Advisor
Chief Financial Officer
Founder & Chief Science Officer
Documentaries, videos and podcasts